Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymoquinone and Metformin in PCOS
NCT04852510Phase 3Completed
- Sponsor
- Saudi German Health
- Start
- Feb 2019
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of thymoquinone in polycystic ovary syndrome (PCOS), sponsored by Saudi German Health. Primary endpoint: Change of menstrual cycle pattern at 6 months. Started Feb 2019; status: completed.
02
Drugs
thymoquinone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT04852510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04852510.